“…Our group has been working on the synthesis of quinazolinone and quinazolinedione derivatives, which are of considerable interest because of their wide array of pharmacological properties [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ]. We have synthesized heterocycles containing the quinazoline-2,4-dione backbone, which are known to exhibit potential anti-hypertensive properties [ 21 , 22 , 23 , 24 , 25 ]. We have described the synthesis of pelanserine ( 5f ), a potent anti-hypertensive agent [ 26 ], and a several quinazoline-2,4-diones with amino acids and dipeptide, which when tested showed mild to no antihypertensive properties [ 27 ].…”